Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Intercept Seeks Long-Term Data To Build Ocaliva Market In PBC

Nov 16 2016

• By Joseph Haas

Liver

Related Content

Intercept's Ocaliva Eyes Vacant Ground In Europe

Oct 17 2016

'Clean Label' For Intercept's Ocaliva In PBC Bodes Well For NASH Claim

Jun 06 2016

Full Data For Intercept's Liver Disease Drug Show Rivals Where To Differentiate

Aug 18 2016

Related Companies

Intercept Pharmaceuticals, Inc.

Novartis AG

Gilead Sciences, Inc.

Amneal Pharmaceuticals, Inc.

Additional Topics

Commercial Business Strategies Launches Post Market Regulation & Studies Rare Diseases Liver & Hepatic BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.